PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-10-06

Date Title Company
06-Oct-2021 Global CRISPR Market 2021-2028 : Rising Ethical Concerns Relating to Technology Use Hampers Overall Development - ResearchAndMarkets.com Businesswire
06-Oct-2021 Rising Migraine Attacks Due To Emotional Disorders Is Driving Demand Of Dual Migraine Treatment Market MARKITWIRED Latest Market Reports
06-Oct-2021 Carotid Stenosis Market Demand Would Drive On High Prevalence Of Heart Related Diseases MARKITWIRED Latest Market Reports
06-Oct-2021 Worldwide Industrial Hemp Industry to 2028 - Featuring Ecofibre, Hemp Oil Canada and Dun Agro Hemp Among Others - ResearchAndMarkets.com Businesswire
06-Oct-2021 Aesthetic Wellness Market Sales Will Gain Significant Traction Due To Demand For Laser Therapy MARKITWIRED Latest Market Reports
06-Oct-2021 Worldwide Motion Sickness Treatment Industry to 2026 - by Manufacturers, Regions, Technology, Application and Product Type - ResearchAndMarkets.com Businesswire
06-Oct-2021 Healthcare Fraud Detection Market Sales Will Significantly Gain Momentum With AI Technology MARKITWIRED Latest Market Reports
06-Oct-2021 Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine Johnson & Johnson
06-Oct-2021 Merck and Emmy-Nominated Actress Yvonne Orji Unveil Uncovering TNBC, Highlighting the Challenges Faced by Black Women Diagnosed with Triple-Negative Breast Cancer Merck
06-Oct-2021 New Culture Medium Supports Expansion of Natural Killer Cells for Cell and Gene Therapies Thermo Fisher Scientific
06-Oct-2021 Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older Moderna
06-Oct-2021 Takeda fornece atualizações sobre o programa clínico TAK-994 Businesswire
06-Oct-2021 Riassunto: Aggiornamento di Takeda sul programma clinico per TAK-994 Businesswire
06-Oct-2021 NHS announces deal for life changing sickle cell treatment NHS England
06-Oct-2021 Merck Licenses Foundational CRISPR Technology to Cellecta, Paving Path for Development of Next-Generation Treatments Merck
06-Oct-2021 London-based Biotech Baccuico Announces $3.8M Seed Round and Name Change to Bactobio Businesswire
06-Oct-2021 ViiV Healthcare submits FDA application for first dispersible single tablet regimen containing dolutegravir (DTG) for children living with HIV ViiV Healthcare
06-Oct-2021 Enterome to Attend Upcoming Conferences ENTEROME SA
06-Oct-2021 DelSiTech Awarded UnitaidExplore Funding for Innovations in Paediatric Healthcare DelSiTech
06-Oct-2021 OXURION to Present at the Lytham Partners Fall 2021 Investor Conference OXURION